|
A new pill that will help control
blood sugar levels and cholesterol for people that have Type
diabetes was approved by a FDA advisory panel on Friday.
Developed from the
drug muraglitazar, Pargluva was developed by Bristol-Meyers
Squibb and Merck & Co. There
is some evidence that Pargluva could increase risk to those with
heart problems. In fact, the advocacy group Public Citizen
argued in a statement Friday that the drug was too risky. Still,
with an estimated 18 million people in the United States with
diabetes, more research is definitely worthy of Pargluva.
Soon we will have an interactive
forum covering all aspects today's drug issues. Until then you
can e-mail us your comments and we will post them to the forum
as soon as it is active. E-mail
Us!
|
| Last
year, the drug industry spent $4.02 billion on ads, up 23
percent from 2003 and 62 percent from 2000, according to
consulting firm IMS Health.
CNN |
|
|
